Broad Therapeutic Effects : Tirzepatide results in clinically significant improvements in multiple obesity-related complications, including sleep apnea, metabolic dysfunction-associated steatohepatitis, heart failure with preserved ejection fraction, and diabetes prevention [79]
Mechanism of Action Incretins hormones like GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) are released throughout the day, increasing at mealtimes
The injection delivers a precise dose of the GLP-1 medication directly into your subcutaneous tissue, where its absorbed into your bloodstream
People who should not use GLP-1s include: Pregnant people People with a personal or family history of medullary thyroid cancer People with multiple endocrine neoplasia syndrome type 2, a rare condition that affects the endocrine glands People who are hypersensitive to GLP-1 agonist drugs GLP-1 Drugs Are Lifelong Treatments Questions to Ask Your Doctor Am I a candidate for a GLP-1 weight loss drug
Weight regain : Many regain lost weight after stopping
For body weight, significant reductions were observed in individuals with overweight/obesity (Class I